nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—CYP3A4—bone cancer	0.867	1	CbGaD
Lurasidone—Ziprasidone—CYP3A4—bone cancer	0.00103	1	CrCbGaD
Lurasidone—Gait disturbance—Doxorubicin—bone cancer	0.000675	0.0051	CcSEcCtD
Lurasidone—Neck pain—Doxorubicin—bone cancer	0.000667	0.00504	CcSEcCtD
Lurasidone—Pulmonary embolism—Doxorubicin—bone cancer	0.000659	0.00498	CcSEcCtD
Lurasidone—Abnormal dreams—Doxorubicin—bone cancer	0.000651	0.00492	CcSEcCtD
Lurasidone—Eye disorder—Cisplatin—bone cancer	0.000651	0.00492	CcSEcCtD
Lurasidone—Cardiac disorder—Cisplatin—bone cancer	0.000646	0.00489	CcSEcCtD
Lurasidone—Salivary hypersecretion—Doxorubicin—bone cancer	0.00064	0.00484	CcSEcCtD
Lurasidone—Diabetes mellitus—Methotrexate—bone cancer	0.000635	0.0048	CcSEcCtD
Lurasidone—Arrhythmia—Cisplatin—bone cancer	0.000622	0.0047	CcSEcCtD
Lurasidone—Malnutrition—Cisplatin—bone cancer	0.000606	0.00458	CcSEcCtD
Lurasidone—Flatulence—Cisplatin—bone cancer	0.000597	0.00452	CcSEcCtD
Lurasidone—Diabetes mellitus—Epirubicin—bone cancer	0.000594	0.00449	CcSEcCtD
Lurasidone—Muscle spasms—Cisplatin—bone cancer	0.000583	0.00441	CcSEcCtD
Lurasidone—Vision blurred—Cisplatin—bone cancer	0.000571	0.00432	CcSEcCtD
Lurasidone—Tremor—Cisplatin—bone cancer	0.000568	0.00429	CcSEcCtD
Lurasidone—Cerebrovascular accident—Methotrexate—bone cancer	0.000564	0.00426	CcSEcCtD
Lurasidone—Lethargy—Methotrexate—bone cancer	0.000564	0.00426	CcSEcCtD
Lurasidone—Anaemia—Cisplatin—bone cancer	0.00056	0.00424	CcSEcCtD
Lurasidone—Hot flush—Epirubicin—bone cancer	0.000553	0.00418	CcSEcCtD
Lurasidone—Osteoarthritis—Methotrexate—bone cancer	0.000552	0.00418	CcSEcCtD
Lurasidone—Increased appetite—Epirubicin—bone cancer	0.00055	0.00416	CcSEcCtD
Lurasidone—Diabetes mellitus—Doxorubicin—bone cancer	0.00055	0.00416	CcSEcCtD
Lurasidone—Menopausal symptoms—Epirubicin—bone cancer	0.000548	0.00414	CcSEcCtD
Lurasidone—Malaise—Cisplatin—bone cancer	0.000547	0.00413	CcSEcCtD
Lurasidone—Leukopenia—Cisplatin—bone cancer	0.000543	0.0041	CcSEcCtD
Lurasidone—Lethargy—Epirubicin—bone cancer	0.000528	0.00399	CcSEcCtD
Lurasidone—Cerebrovascular accident—Epirubicin—bone cancer	0.000528	0.00399	CcSEcCtD
Lurasidone—Convulsion—Cisplatin—bone cancer	0.000525	0.00397	CcSEcCtD
Lurasidone—Osteoarthritis—Epirubicin—bone cancer	0.000517	0.00391	CcSEcCtD
Lurasidone—Myalgia—Cisplatin—bone cancer	0.000516	0.0039	CcSEcCtD
Lurasidone—Anxiety—Cisplatin—bone cancer	0.000514	0.00389	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000513	0.00387	CcSEcCtD
Lurasidone—Hot flush—Doxorubicin—bone cancer	0.000511	0.00387	CcSEcCtD
Lurasidone—Increased appetite—Doxorubicin—bone cancer	0.000509	0.00385	CcSEcCtD
Lurasidone—Menopausal symptoms—Doxorubicin—bone cancer	0.000507	0.00383	CcSEcCtD
Lurasidone—Breast disorder—Methotrexate—bone cancer	0.000499	0.00377	CcSEcCtD
Lurasidone—Infection—Cisplatin—bone cancer	0.000492	0.00372	CcSEcCtD
Lurasidone—Lethargy—Doxorubicin—bone cancer	0.000488	0.00369	CcSEcCtD
Lurasidone—Cerebrovascular accident—Doxorubicin—bone cancer	0.000488	0.00369	CcSEcCtD
Lurasidone—Nervous system disorder—Cisplatin—bone cancer	0.000485	0.00367	CcSEcCtD
Lurasidone—Blood creatinine increased—Epirubicin—bone cancer	0.000484	0.00366	CcSEcCtD
Lurasidone—Tachycardia—Cisplatin—bone cancer	0.000483	0.00365	CcSEcCtD
Lurasidone—Skin disorder—Cisplatin—bone cancer	0.000481	0.00363	CcSEcCtD
Lurasidone—Osteoarthritis—Doxorubicin—bone cancer	0.000478	0.00362	CcSEcCtD
Lurasidone—Hyperhidrosis—Cisplatin—bone cancer	0.000478	0.00362	CcSEcCtD
Lurasidone—Eosinophilia—Methotrexate—bone cancer	0.000473	0.00357	CcSEcCtD
Lurasidone—Abdominal pain upper—Epirubicin—bone cancer	0.000472	0.00357	CcSEcCtD
Lurasidone—Orthostatic hypotension—Epirubicin—bone cancer	0.000472	0.00357	CcSEcCtD
Lurasidone—Breast disorder—Epirubicin—bone cancer	0.000467	0.00353	CcSEcCtD
Lurasidone—Hypotension—Cisplatin—bone cancer	0.000462	0.00349	CcSEcCtD
Lurasidone—Nasopharyngitis—Epirubicin—bone cancer	0.000462	0.00349	CcSEcCtD
Lurasidone—Abdominal discomfort—Methotrexate—bone cancer	0.000458	0.00346	CcSEcCtD
Lurasidone—Gastritis—Epirubicin—bone cancer	0.000458	0.00346	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000456	0.00345	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000451	0.00341	CcSEcCtD
Lurasidone—Blood creatinine increased—Doxorubicin—bone cancer	0.000448	0.00339	CcSEcCtD
Lurasidone—Influenza—Epirubicin—bone cancer	0.000447	0.00338	CcSEcCtD
Lurasidone—Dysphagia—Epirubicin—bone cancer	0.000447	0.00338	CcSEcCtD
Lurasidone—Neutropenia—Methotrexate—bone cancer	0.000446	0.00337	CcSEcCtD
Lurasidone—Dysuria—Methotrexate—bone cancer	0.000446	0.00337	CcSEcCtD
Lurasidone—Eosinophilia—Epirubicin—bone cancer	0.000442	0.00334	CcSEcCtD
Lurasidone—Dyspnoea—Cisplatin—bone cancer	0.000441	0.00333	CcSEcCtD
Lurasidone—Erectile dysfunction—Methotrexate—bone cancer	0.00044	0.00332	CcSEcCtD
Lurasidone—Abdominal pain upper—Doxorubicin—bone cancer	0.000437	0.0033	CcSEcCtD
Lurasidone—Orthostatic hypotension—Doxorubicin—bone cancer	0.000437	0.0033	CcSEcCtD
Lurasidone—Angina pectoris—Epirubicin—bone cancer	0.000435	0.00329	CcSEcCtD
Lurasidone—Breast disorder—Doxorubicin—bone cancer	0.000432	0.00327	CcSEcCtD
Lurasidone—Decreased appetite—Cisplatin—bone cancer	0.00043	0.00325	CcSEcCtD
Lurasidone—Nasopharyngitis—Doxorubicin—bone cancer	0.000428	0.00323	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000427	0.00323	CcSEcCtD
Lurasidone—Infestation—Methotrexate—bone cancer	0.000426	0.00322	CcSEcCtD
Lurasidone—Infestation NOS—Methotrexate—bone cancer	0.000426	0.00322	CcSEcCtD
Lurasidone—Gastritis—Doxorubicin—bone cancer	0.000423	0.0032	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000422	0.00319	CcSEcCtD
Lurasidone—Renal failure—Methotrexate—bone cancer	0.000418	0.00316	CcSEcCtD
Lurasidone—Dysuria—Epirubicin—bone cancer	0.000418	0.00316	CcSEcCtD
Lurasidone—Neutropenia—Epirubicin—bone cancer	0.000418	0.00316	CcSEcCtD
Lurasidone—Influenza—Doxorubicin—bone cancer	0.000413	0.00312	CcSEcCtD
Lurasidone—Dysphagia—Doxorubicin—bone cancer	0.000413	0.00312	CcSEcCtD
Lurasidone—Eosinophilia—Doxorubicin—bone cancer	0.000409	0.00309	CcSEcCtD
Lurasidone—Weight increased—Epirubicin—bone cancer	0.000407	0.00307	CcSEcCtD
Lurasidone—Hyperglycaemia—Epirubicin—bone cancer	0.000403	0.00305	CcSEcCtD
Lurasidone—Angina pectoris—Doxorubicin—bone cancer	0.000403	0.00304	CcSEcCtD
Lurasidone—Hepatobiliary disease—Methotrexate—bone cancer	0.000403	0.00304	CcSEcCtD
Lurasidone—Infestation—Epirubicin—bone cancer	0.000398	0.00301	CcSEcCtD
Lurasidone—Infestation NOS—Epirubicin—bone cancer	0.000398	0.00301	CcSEcCtD
Lurasidone—Agranulocytosis—Methotrexate—bone cancer	0.000397	0.003	CcSEcCtD
Lurasidone—Renal failure—Epirubicin—bone cancer	0.000392	0.00296	CcSEcCtD
Lurasidone—Urinary tract infection—Epirubicin—bone cancer	0.000387	0.00293	CcSEcCtD
Lurasidone—Neutropenia—Doxorubicin—bone cancer	0.000387	0.00292	CcSEcCtD
Lurasidone—Dysuria—Doxorubicin—bone cancer	0.000387	0.00292	CcSEcCtD
Lurasidone—Urinary tract disorder—Methotrexate—bone cancer	0.000377	0.00285	CcSEcCtD
Lurasidone—Hepatobiliary disease—Epirubicin—bone cancer	0.000377	0.00285	CcSEcCtD
Lurasidone—Weight increased—Doxorubicin—bone cancer	0.000376	0.00284	CcSEcCtD
Lurasidone—Urethral disorder—Methotrexate—bone cancer	0.000375	0.00283	CcSEcCtD
Lurasidone—Hyperglycaemia—Doxorubicin—bone cancer	0.000373	0.00282	CcSEcCtD
Lurasidone—Agranulocytosis—Epirubicin—bone cancer	0.000372	0.00281	CcSEcCtD
Lurasidone—Infestation NOS—Doxorubicin—bone cancer	0.000369	0.00279	CcSEcCtD
Lurasidone—Infestation—Doxorubicin—bone cancer	0.000369	0.00279	CcSEcCtD
Lurasidone—Bradycardia—Epirubicin—bone cancer	0.000364	0.00275	CcSEcCtD
Lurasidone—Renal failure—Doxorubicin—bone cancer	0.000362	0.00274	CcSEcCtD
Lurasidone—Urinary tract infection—Doxorubicin—bone cancer	0.000358	0.00271	CcSEcCtD
Lurasidone—Eye disorder—Methotrexate—bone cancer	0.000357	0.0027	CcSEcCtD
Lurasidone—Asthenia—Cisplatin—bone cancer	0.000355	0.00268	CcSEcCtD
Lurasidone—Cardiac disorder—Methotrexate—bone cancer	0.000355	0.00268	CcSEcCtD
Lurasidone—Urinary tract disorder—Epirubicin—bone cancer	0.000353	0.00267	CcSEcCtD
Lurasidone—Connective tissue disorder—Epirubicin—bone cancer	0.000351	0.00266	CcSEcCtD
Lurasidone—Urethral disorder—Epirubicin—bone cancer	0.000351	0.00265	CcSEcCtD
Lurasidone—Hepatobiliary disease—Doxorubicin—bone cancer	0.000349	0.00264	CcSEcCtD
Lurasidone—Angiopathy—Methotrexate—bone cancer	0.000347	0.00262	CcSEcCtD
Lurasidone—Agranulocytosis—Doxorubicin—bone cancer	0.000344	0.0026	CcSEcCtD
Lurasidone—Diarrhoea—Cisplatin—bone cancer	0.000339	0.00256	CcSEcCtD
Lurasidone—Bradycardia—Doxorubicin—bone cancer	0.000337	0.00255	CcSEcCtD
Lurasidone—Mental disorder—Methotrexate—bone cancer	0.000335	0.00253	CcSEcCtD
Lurasidone—Eye disorder—Epirubicin—bone cancer	0.000334	0.00253	CcSEcCtD
Lurasidone—Malnutrition—Methotrexate—bone cancer	0.000333	0.00251	CcSEcCtD
Lurasidone—Cardiac disorder—Epirubicin—bone cancer	0.000332	0.00251	CcSEcCtD
Lurasidone—Urinary tract disorder—Doxorubicin—bone cancer	0.000327	0.00247	CcSEcCtD
Lurasidone—Connective tissue disorder—Doxorubicin—bone cancer	0.000325	0.00246	CcSEcCtD
Lurasidone—Angiopathy—Epirubicin—bone cancer	0.000324	0.00245	CcSEcCtD
Lurasidone—Urethral disorder—Doxorubicin—bone cancer	0.000324	0.00245	CcSEcCtD
Lurasidone—Back pain—Methotrexate—bone cancer	0.000322	0.00243	CcSEcCtD
Lurasidone—Arrhythmia—Epirubicin—bone cancer	0.00032	0.00241	CcSEcCtD
Lurasidone—Vomiting—Cisplatin—bone cancer	0.000315	0.00238	CcSEcCtD
Lurasidone—Vision blurred—Methotrexate—bone cancer	0.000314	0.00237	CcSEcCtD
Lurasidone—Mental disorder—Epirubicin—bone cancer	0.000313	0.00237	CcSEcCtD
Lurasidone—Rash—Cisplatin—bone cancer	0.000312	0.00236	CcSEcCtD
Lurasidone—Dermatitis—Cisplatin—bone cancer	0.000312	0.00236	CcSEcCtD
Lurasidone—Malnutrition—Epirubicin—bone cancer	0.000311	0.00235	CcSEcCtD
Lurasidone—Eye disorder—Doxorubicin—bone cancer	0.000309	0.00234	CcSEcCtD
Lurasidone—Anaemia—Methotrexate—bone cancer	0.000307	0.00232	CcSEcCtD
Lurasidone—Cardiac disorder—Doxorubicin—bone cancer	0.000307	0.00232	CcSEcCtD
Lurasidone—Flatulence—Epirubicin—bone cancer	0.000307	0.00232	CcSEcCtD
Lurasidone—Back pain—Epirubicin—bone cancer	0.000301	0.00228	CcSEcCtD
Lurasidone—Angiopathy—Doxorubicin—bone cancer	0.0003	0.00227	CcSEcCtD
Lurasidone—Malaise—Methotrexate—bone cancer	0.0003	0.00227	CcSEcCtD
Lurasidone—Muscle spasms—Epirubicin—bone cancer	0.000299	0.00226	CcSEcCtD
Lurasidone—Vertigo—Methotrexate—bone cancer	0.000299	0.00226	CcSEcCtD
Lurasidone—Leukopenia—Methotrexate—bone cancer	0.000298	0.00225	CcSEcCtD
Lurasidone—Arrhythmia—Doxorubicin—bone cancer	0.000296	0.00223	CcSEcCtD
Lurasidone—Nausea—Cisplatin—bone cancer	0.000294	0.00222	CcSEcCtD
Lurasidone—Vision blurred—Epirubicin—bone cancer	0.000293	0.00222	CcSEcCtD
Lurasidone—Mental disorder—Doxorubicin—bone cancer	0.00029	0.00219	CcSEcCtD
Lurasidone—Convulsion—Methotrexate—bone cancer	0.000288	0.00218	CcSEcCtD
Lurasidone—Malnutrition—Doxorubicin—bone cancer	0.000288	0.00218	CcSEcCtD
Lurasidone—Anaemia—Epirubicin—bone cancer	0.000288	0.00218	CcSEcCtD
Lurasidone—Agitation—Epirubicin—bone cancer	0.000286	0.00216	CcSEcCtD
Lurasidone—Flatulence—Doxorubicin—bone cancer	0.000284	0.00215	CcSEcCtD
Lurasidone—Myalgia—Methotrexate—bone cancer	0.000283	0.00214	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000281	0.00213	CcSEcCtD
Lurasidone—Malaise—Epirubicin—bone cancer	0.000281	0.00212	CcSEcCtD
Lurasidone—Vertigo—Epirubicin—bone cancer	0.00028	0.00211	CcSEcCtD
Lurasidone—Syncope—Epirubicin—bone cancer	0.000279	0.00211	CcSEcCtD
Lurasidone—Leukopenia—Epirubicin—bone cancer	0.000279	0.00211	CcSEcCtD
Lurasidone—Back pain—Doxorubicin—bone cancer	0.000279	0.00211	CcSEcCtD
Lurasidone—Muscle spasms—Doxorubicin—bone cancer	0.000277	0.00209	CcSEcCtD
Lurasidone—Loss of consciousness—Epirubicin—bone cancer	0.000274	0.00207	CcSEcCtD
Lurasidone—Vision blurred—Doxorubicin—bone cancer	0.000271	0.00205	CcSEcCtD
Lurasidone—Convulsion—Epirubicin—bone cancer	0.00027	0.00204	CcSEcCtD
Lurasidone—Infection—Methotrexate—bone cancer	0.00027	0.00204	CcSEcCtD
Lurasidone—Hypertension—Epirubicin—bone cancer	0.000269	0.00203	CcSEcCtD
Lurasidone—Nervous system disorder—Methotrexate—bone cancer	0.000266	0.00201	CcSEcCtD
Lurasidone—Anaemia—Doxorubicin—bone cancer	0.000266	0.00201	CcSEcCtD
Lurasidone—Myalgia—Epirubicin—bone cancer	0.000265	0.002	CcSEcCtD
Lurasidone—Agitation—Doxorubicin—bone cancer	0.000265	0.002	CcSEcCtD
Lurasidone—Anxiety—Epirubicin—bone cancer	0.000264	0.002	CcSEcCtD
Lurasidone—Skin disorder—Methotrexate—bone cancer	0.000264	0.00199	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000263	0.00199	CcSEcCtD
Lurasidone—Hyperhidrosis—Methotrexate—bone cancer	0.000262	0.00198	CcSEcCtD
Lurasidone—Malaise—Doxorubicin—bone cancer	0.00026	0.00196	CcSEcCtD
Lurasidone—Dry mouth—Epirubicin—bone cancer	0.000259	0.00196	CcSEcCtD
Lurasidone—Vertigo—Doxorubicin—bone cancer	0.000259	0.00196	CcSEcCtD
Lurasidone—Syncope—Doxorubicin—bone cancer	0.000258	0.00195	CcSEcCtD
Lurasidone—Leukopenia—Doxorubicin—bone cancer	0.000258	0.00195	CcSEcCtD
Lurasidone—Hypotension—Methotrexate—bone cancer	0.000254	0.00192	CcSEcCtD
Lurasidone—Loss of consciousness—Doxorubicin—bone cancer	0.000253	0.00191	CcSEcCtD
Lurasidone—Infection—Epirubicin—bone cancer	0.000252	0.00191	CcSEcCtD
Lurasidone—Shock—Epirubicin—bone cancer	0.00025	0.00189	CcSEcCtD
Lurasidone—Convulsion—Doxorubicin—bone cancer	0.00025	0.00189	CcSEcCtD
Lurasidone—Nervous system disorder—Epirubicin—bone cancer	0.000249	0.00188	CcSEcCtD
Lurasidone—Hypertension—Doxorubicin—bone cancer	0.000249	0.00188	CcSEcCtD
Lurasidone—Tachycardia—Epirubicin—bone cancer	0.000248	0.00187	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000247	0.00187	CcSEcCtD
Lurasidone—Skin disorder—Epirubicin—bone cancer	0.000247	0.00187	CcSEcCtD
Lurasidone—Hyperhidrosis—Epirubicin—bone cancer	0.000246	0.00186	CcSEcCtD
Lurasidone—Insomnia—Methotrexate—bone cancer	0.000246	0.00186	CcSEcCtD
Lurasidone—Myalgia—Doxorubicin—bone cancer	0.000245	0.00185	CcSEcCtD
Lurasidone—Anxiety—Doxorubicin—bone cancer	0.000244	0.00185	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000244	0.00184	CcSEcCtD
Lurasidone—Dyspnoea—Methotrexate—bone cancer	0.000242	0.00183	CcSEcCtD
Lurasidone—Somnolence—Methotrexate—bone cancer	0.000241	0.00182	CcSEcCtD
Lurasidone—Dry mouth—Doxorubicin—bone cancer	0.00024	0.00181	CcSEcCtD
Lurasidone—Dyspepsia—Methotrexate—bone cancer	0.000239	0.00181	CcSEcCtD
Lurasidone—Hypotension—Epirubicin—bone cancer	0.000237	0.00179	CcSEcCtD
Lurasidone—Decreased appetite—Methotrexate—bone cancer	0.000236	0.00178	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000234	0.00177	CcSEcCtD
Lurasidone—Fatigue—Methotrexate—bone cancer	0.000234	0.00177	CcSEcCtD
Lurasidone—Infection—Doxorubicin—bone cancer	0.000234	0.00177	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000232	0.00175	CcSEcCtD
Lurasidone—Shock—Doxorubicin—bone cancer	0.000231	0.00175	CcSEcCtD
Lurasidone—Nervous system disorder—Doxorubicin—bone cancer	0.000231	0.00174	CcSEcCtD
Lurasidone—Insomnia—Epirubicin—bone cancer	0.00023	0.00174	CcSEcCtD
Lurasidone—Tachycardia—Doxorubicin—bone cancer	0.000229	0.00173	CcSEcCtD
Lurasidone—Skin disorder—Doxorubicin—bone cancer	0.000228	0.00173	CcSEcCtD
Lurasidone—Hyperhidrosis—Doxorubicin—bone cancer	0.000227	0.00172	CcSEcCtD
Lurasidone—Dyspnoea—Epirubicin—bone cancer	0.000227	0.00171	CcSEcCtD
Lurasidone—Somnolence—Epirubicin—bone cancer	0.000226	0.00171	CcSEcCtD
Lurasidone—Dyspepsia—Epirubicin—bone cancer	0.000224	0.00169	CcSEcCtD
Lurasidone—Gastrointestinal pain—Methotrexate—bone cancer	0.000222	0.00168	CcSEcCtD
Lurasidone—Decreased appetite—Epirubicin—bone cancer	0.000221	0.00167	CcSEcCtD
Lurasidone—Hypotension—Doxorubicin—bone cancer	0.00022	0.00166	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000219	0.00166	CcSEcCtD
Lurasidone—Fatigue—Epirubicin—bone cancer	0.000219	0.00166	CcSEcCtD
Lurasidone—Abdominal pain—Methotrexate—bone cancer	0.000215	0.00162	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000214	0.00162	CcSEcCtD
Lurasidone—Insomnia—Doxorubicin—bone cancer	0.000213	0.00161	CcSEcCtD
Lurasidone—Dyspnoea—Doxorubicin—bone cancer	0.00021	0.00158	CcSEcCtD
Lurasidone—Somnolence—Doxorubicin—bone cancer	0.000209	0.00158	CcSEcCtD
Lurasidone—Gastrointestinal pain—Epirubicin—bone cancer	0.000208	0.00157	CcSEcCtD
Lurasidone—Dyspepsia—Doxorubicin—bone cancer	0.000207	0.00156	CcSEcCtD
Lurasidone—Decreased appetite—Doxorubicin—bone cancer	0.000204	0.00154	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000203	0.00153	CcSEcCtD
Lurasidone—Fatigue—Doxorubicin—bone cancer	0.000203	0.00153	CcSEcCtD
Lurasidone—Abdominal pain—Epirubicin—bone cancer	0.000201	0.00152	CcSEcCtD
Lurasidone—Asthenia—Methotrexate—bone cancer	0.000195	0.00147	CcSEcCtD
Lurasidone—Gastrointestinal pain—Doxorubicin—bone cancer	0.000192	0.00145	CcSEcCtD
Lurasidone—Pruritus—Methotrexate—bone cancer	0.000192	0.00145	CcSEcCtD
Lurasidone—Abdominal pain—Doxorubicin—bone cancer	0.000186	0.0014	CcSEcCtD
Lurasidone—Diarrhoea—Methotrexate—bone cancer	0.000186	0.0014	CcSEcCtD
Lurasidone—Asthenia—Epirubicin—bone cancer	0.000182	0.00138	CcSEcCtD
Lurasidone—Pruritus—Epirubicin—bone cancer	0.00018	0.00136	CcSEcCtD
Lurasidone—Dizziness—Methotrexate—bone cancer	0.00018	0.00136	CcSEcCtD
Lurasidone—Diarrhoea—Epirubicin—bone cancer	0.000174	0.00131	CcSEcCtD
Lurasidone—Vomiting—Methotrexate—bone cancer	0.000173	0.0013	CcSEcCtD
Lurasidone—Rash—Methotrexate—bone cancer	0.000171	0.00129	CcSEcCtD
Lurasidone—Dermatitis—Methotrexate—bone cancer	0.000171	0.00129	CcSEcCtD
Lurasidone—Asthenia—Doxorubicin—bone cancer	0.000169	0.00127	CcSEcCtD
Lurasidone—Dizziness—Epirubicin—bone cancer	0.000168	0.00127	CcSEcCtD
Lurasidone—Pruritus—Doxorubicin—bone cancer	0.000166	0.00126	CcSEcCtD
Lurasidone—Vomiting—Epirubicin—bone cancer	0.000162	0.00122	CcSEcCtD
Lurasidone—Nausea—Methotrexate—bone cancer	0.000161	0.00122	CcSEcCtD
Lurasidone—Diarrhoea—Doxorubicin—bone cancer	0.000161	0.00122	CcSEcCtD
Lurasidone—Rash—Epirubicin—bone cancer	0.00016	0.00121	CcSEcCtD
Lurasidone—Dermatitis—Epirubicin—bone cancer	0.00016	0.00121	CcSEcCtD
Lurasidone—Dizziness—Doxorubicin—bone cancer	0.000155	0.00118	CcSEcCtD
Lurasidone—Nausea—Epirubicin—bone cancer	0.000151	0.00114	CcSEcCtD
Lurasidone—Vomiting—Doxorubicin—bone cancer	0.000149	0.00113	CcSEcCtD
Lurasidone—Rash—Doxorubicin—bone cancer	0.000148	0.00112	CcSEcCtD
Lurasidone—Dermatitis—Doxorubicin—bone cancer	0.000148	0.00112	CcSEcCtD
Lurasidone—Nausea—Doxorubicin—bone cancer	0.00014	0.00106	CcSEcCtD
